Trials / Completed
CompletedNCT05696938
Improved Skin Whitening Outcomes Associated With Nicotinamide Fortified Consumption in 30 to 50- Year-old Women
Improved Skin Whitening Outcomes Associated With Nicotinamide Fortified Consumption in 30 to 50-Year-old Women, a Double Blind, Control and Randomized Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 70 (actual)
- Sponsor
- Shenzhen Precision Health Food Technology Co. Ltd., · Other Government
- Sex
- Female
- Age
- 30 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The goal of this clinical trial is to study whether the products with nicotinamide fortified could improve skin whitening in 30 to 50-year-old women. Partipants will be randomly assigned to two study groups and use products (study product plus nicotinamide supplement and placebo product without nicotinamide supplement) for 2 months, twice a day. Researchers will compare the two groups whether there are significant improvement in skin whitening via skin measurement and analysis systems.
Detailed description
This study is two arms, randomized, double-blind controlled trial. 70 eligible partipants at two study sites will be enrolled and use randomly assigned products (study product plus nicotinamide supplement and placebo product) for 2 months. Participants will visit the study site for three times on baseline day, day 30, and day 60, all relevant data will be captured, measured via professional skin equipment system and recorded in the data management system. At the end of study, the explantory and statisitcal analysis will be conducted to validate the assumption that the using products with nicotinamide fortified could improve skin whitening in 30 to 50-year-old women.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Wonderlab Nicotinamide Drink | Participants in this arm will use a bottle of 25ml each time, twice a day, for 2 months. |
| DIETARY_SUPPLEMENT | Ordinary Drink | Participants in this arm will use a bottle of 25ml each time, twice a day, for 2 months. |
Timeline
- Start date
- 2023-02-16
- Primary completion
- 2023-04-26
- Completion
- 2023-04-26
- First posted
- 2023-01-25
- Last updated
- 2023-11-24
Locations
2 sites across 1 country: China
Source: ClinicalTrials.gov record NCT05696938. Inclusion in this directory is not an endorsement.